osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'lung', 'aura ,(-laura)']
#esmo22 #lcsm adaura updates using osi in adjuvant setting : *recurrence patterns*
lung (12 vs 26%) cns (6 vs 11%)
lymph nodes (6 vs 17%) 
Thoracic oncologist & researcher @IEOufficiale; @myESMO Press & Media Chair; #LungCancer Molecular target-believer #LCSM